drugset / Trial / NCT06067893

Low Dose Dexmedetomidine as a Postoperative Pain Adjunct

NCT06067893 ↗

Phase 4 Enrolling by invitation 160 enrolled Nichole Doyle
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This randomized controlled trial examines whether the addition of a low-dose dexmedetomidine infusion to our current multimodal pain management plan decreases narcotic consumption and reduces side effects in adolescent patients undergoing posterior spinal fusion for idiopathic scoliosis.

Timeline

Start
2024-07-01
Primary completion
2026-07
Completion
2026-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.2 ug/kg —